- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.05. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 27.05. | Catheter Precision Inc.: Catheter Precision, Inc. Receives CE Mark for LockeT | 1 | GlobeNewswire (USA) | ||
| 19.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Catheter Precision reports Q1 results | 3 | Seeking Alpha | ||
| 14.05. | Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | 1.064 | GlobeNewswire (Europe) | FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 13.05. | Catheter Precision raises $1.5M via private placement | 2 | Seeking Alpha | ||
| 13.05. | Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | 5 | GlobeNewswire (USA) | ||
| 08.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Catheter Precision to acquire late-stage heart failure treatment assets in development | 1 | Seeking Alpha | ||
| 17.04. | Catheter Precision, Inc.: Catheter Precision Makes NYSE American Section 610(b) Public Announcement | 1 | GlobeNewswire (USA) | ||
| 16.04. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | Catheter Precision, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 28.03. | Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results | 271 | GlobeNewswire (Europe) | FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 12.03. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 06.02. | Catheter Precision, Inc.: Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage | 3 | GlobeNewswire (USA) | ||
| 04.02. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.02. | Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC | 1 | GlobeNewswire (USA) | ||
| 17.01. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.01. | Catheter Precision, Inc: Catheter Precision to Attend the 30th International Atrial Fibrillation Symposium | 229 | ACCESS Newswire | FORT MILL, SOUTH CAROLINA / ACCESS Newswire / January 16, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products... ► Artikel lesen |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,290 | +0,11 % | DAX-Check LIVE: Bilfinger, Cancom, Delivery Hero, Fresenius, Gerresheimer, Rheinmetall im Fokus | Der DAX hat den gestrigen Handelstag mit leichten Verlusten beendet. Der deutsche Leitindex schloss 0,28 Prozent tiefer bei 23.930 Punkten. Zwar konnte er sich am Nachmittag vom Tagestief bei 23.740... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,32 | -0,40 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 41,50 Euro auf "Underweight" belassen. Die Anleger warteten auf neue Mittelfristziele und Neuigkeiten... ► Artikel lesen | |
| ECKERT & ZIEGLER | 65,05 | -3,49 % | Eckert&Ziegler-Aktie leicht im Plus (62,55 €) | Der Anteilsschein von Eckert&Ziegler notiert am Montag etwas fester. Der jüngste Kurs betrug 62,55 Euro. Freuen können sich gegenwärtig die Aktionäre von Eckert&Ziegler: Die Aktie weist gegenwärtig... ► Artikel lesen | |
| BICO GROUP | 3,360 | +0,12 % | Toni Haberthür, CEO Bico / Hilding Anders Switzerland, im Interview | von Patrick Gunti Moneycab.com: Herr Haberthür, Bico steht «für ä tüüfä gsundä Schlaaf» und ist seit Jahrzehnten die bekannteste Marke der Schweiz im Bereich hochwertiger Schlaflösungen. Wie prägt die... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,111 | 0,00 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
| CARDINAL HEALTH | 135,70 | -0,04 % | Cardinal Health Launches 3-in-1 Continuous Vital Signs Monitoring System | WASHINGTON (dpa-AFX) - Cardinal Health Inc (CAH) Wednesday said it has launched Kendall DL Multi System, a new medical device to help continuously monitor three vital signs including cardiac... ► Artikel lesen | |
| RESMED | 220,50 | -0,36 % | RESMED INC: Notice of Proposed Sale of Securities | ||
| ATOSSA THERAPEUTICS | 0,800 | +8,40 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
| UNIDOC HEALTH | 0,164 | -1,92 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
| ZIMMER BIOMET | 80,66 | -0,49 % | Treace Medical Concepts, Inc.: Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty Bunion Technology | PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 3,040 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain | BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,274 | +3,01 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,525 | -3,40 % | Veru Inc.: Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide ... | --Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial... ► Artikel lesen | |
| CYTOSORBENTS | 0,884 | -4,54 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 5,240 | -100,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,215 Euro und damit +6,71 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.